179 related articles for article (PubMed ID: 15507262)
1. Inflammatory response and the endothelium.
Meroni PL; Borghi MO; Raschi E; Ventura D; Sarzi Puttini PC; Atzeni F; Lonati L; Parati G; Tincani A; Mari D; Tedesco F
Thromb Res; 2004; 114(5-6):329-34. PubMed ID: 15507262
[TBL] [Abstract][Full Text] [Related]
2. Patients with antiphospholipid syndrome display endothelial perturbation.
Cugno M; Borghi MO; Lonati LM; Ghiadoni L; Gerosa M; Grossi C; De Angelis V; Magnaghi G; Tincani A; Mari D; Riboldi P; Meroni PL
J Autoimmun; 2010 Mar; 34(2):105-10. PubMed ID: 19656656
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
4. Systemic endothelial cell markers in primary antiphospholipid syndrome.
Williams FM; Parmar K; Hughes GR; Hunt BJ
Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
[TBL] [Abstract][Full Text] [Related]
5. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
6. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V
Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
[TBL] [Abstract][Full Text] [Related]
7. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
8. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
9. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
10. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
11. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
12. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
[TBL] [Abstract][Full Text] [Related]
13. [Endothelial dysfunction in a family with familial combined hyperlipidemia].
Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L
Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086
[TBL] [Abstract][Full Text] [Related]
14. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
15. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies.
Meroni PL; Raschi E; Testoni C; Parisio A; Borghi MO
Autoimmun Rev; 2004 Nov; 3(7-8):510-5. PubMed ID: 15546799
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
18. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
20. Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome.
Walenga JM; Michal K; Hoppensteadt D; Wood JJ; Robinson JA; Bick RL
Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S76-84. PubMed ID: 10726041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
